Evidence map›Paper›PMID 42144285›Full record

SynthesisPhytotherapy research : PTR2026

Flavonoids in Nasal Therapeutics: Biological Activities, Delivery Challenges, and Formulation Strategies-A Systematic Review.

Jeniffer Viviana Ramirez Hernández, Sara Elis Bianchi, Flávia Nathiely Silveira Fachel, Elizandra Braganhol, Sheila Porto de Matos, Valquíria Linck Bassani

Abstract readSystematic Review
In one paragraph

Synthesis in Phytotherapy research : PTR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jeniffer Viviana Ramirez HernándezPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.ORCID https://orcid.org/0009-0003-5267-1607
Sara Elis BianchiPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Flávia Nathiely Silveira FachelPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Elizandra BraganholPrograma de Pós-Graduação Em Biociências, Universidade de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, Brazil.
Sheila Porto de MatosPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Valquíria Linck BassaniPrograma de Pós-Graduação Em Ciências Farmacêuticas, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.ORCID https://orcid.org/0000-0001-9525-5855

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305490/2022-2Conselho Nacional de Desenvolvimento Científico e Tecnológico 406218/2025-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

Flavonoids represent a significant group of secondary metabolites. They have gained significant attention in the field of health due to their wide range of chemical structures and their diverse biological activities. These compounds have been most commonly administered orally as sugar conjugates (heterosides). Flavonoid nasal administration emerges as a therapeutic strategy, with potential for local, systemic, or targeted flavonoid actions, mainly in the free form (aglycones). This study provides a systematic and comprehensive review of flavonoid classes and administration routes, emphasizing their roles at three levels of the nasal administration route. Following PRISMA guidelines, a systematic search was conducted in Web of Science and PubMed (December 1997-November 2024), retrieving 225 records, of which 40 met the inclusion criteria. The first one is in the nasal cavity, highlighting its beneficial effects on the nasal mucosal epithelia (topical effect); the second is the flavonoid administration for treating naso-respiratory and other diseases, and the third is how the flavonoid can be targeted to the brain, taking advantage of the nose-to-brain route to prevent or treat CNS diseases.

Indexed as

FlavonoidsAdministration, IntranasalAnimalsHumansNasal MucosaFlavonoidsadministration routesflavonoidsnasal administrationnose‐to‐brainrespiratory diseases

Identifiers

PMID42144285
PMCPMC13340958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.